No Prescription |
 |
 | ||
|
PHEXIN Biocef |
|
| ||
No Prescription » Prescription Drugs 13 » PHEXIN Biocef Cephalexin is a cephalosporin antibiotic used to treat certain infections caused by bacteria such as pneumonia and bone ear skin and urinary tract infections. Antibiotics will not work for colds flu or other viral infections.Cephalexin comes as a capsule tablet and liquid to take by mouth. It is usually taken every 6 hours (four times a day) or every 12 hours (twice a day) for 7-10 days. Follow the directions on your prescription label carefully and ask your doctor or pharmacist to explain any part you do not understand. Take cephalexin exactly as directed. Do not take more or less of it or take it more often than prescribed by your doctor.Shake the liquid well before each use to mix the medication evenly.The capsules and tablets should be swallowed whole and taken with a full glass of water.Continue to take cephalexin even if you feel well. Do not stop taking cephalexin without talking to your doctor. Buy PHEXIN Biocef and other Prescription Drugs 13 products online at Medstore. 898
About PHEXIN Biocef: Product Type: Prescription Drugs 13 PHEXIN ( Biocef Keflex Keftab Generic Cephalexin ) PHEXIN (Biocef Keflex Keftab Generic Cephalexin) Biocef Keflex Keftab Generic Cephalexin 250mg Caps 10 Biocef Keflex Keftab Generic Cephalexin PHEXIN
View more Prescription Drugs 13 No Prescription: NEW YORK, Oct. 5, 2011 /PRNewswire via COMTEX/ -- Reportlinker.com announces that a new market research report is available in its catalogue: European Pharmaceutical Market: Strategic Assessments of Leading Suppliers http://www.reportlinker.com/p0651431/European-Pharmaceutical-Market-Strategic-Assessments-of-Leading-Suppliers.html #utm_source=prnewswire&utm_medium=pr&utm_campaign=Drug_and_Medication This report provides industry executives with strategically significant competitor information and analysis of the leading players in the European pharmaceutical market. The report provides a worldwide strategic overview of the pharmaceutical market, including: Sales forecast for major product segments: ethical, OTC, generics. Sales forecast for major drug categories: cardiovascular, gastrointestinal, antibiotic, CNS, respiratory, musculoskeletal, hormonal/genitourinary, dermatological, oncological, ophthalmic, and others. In addition, the report reviews major regulatory, technological, economic, demographic, and social trends with potentially significant impact on the market during the next five years, including discussion of such key issues as pricing, industry consolidation, market globalization, growing R&D cost, generics, as well as advances in genomics, proteomics, drug screening, tissue engineering, bioinformatics, and other technologies. The companies analyzed in this report include Abbott, AstraZeneca, Bristol-Myers Squibb, Eli Lilly, GlaxoSmithKline, Johnson & Johnson, Merck, Novartis, Pfizer, Roche, Sanofi-Aventis and Wyeth.
| ||
